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ABSTRACT
Objective To investigate whether knowing the diagnosis
for sickness absence improves prediction of mortality.
Design Prospective cohort study established in 1985-8.
Sickness absence records including diagnoses were
obtained from computerised registers.
Setting 20 civil service departments in London.
Participants 6478 civil servants aged 35-55 years.
Main outcome measures All cause, cardiovascular, and
cancer mortality until 2004, average follow-up 13 years.
Results After adjustment for age, sex, and employment
grade,employeeswhohadoneormoremedicallycertified
spellsofsicknessabsence(>7days)inathreeyearperiod
had a mortality 1.7 (95% CI 1.3 to 2.1) times greater than
those with no medically certified spells. Inclusion of
diagnoses improved the prediction of all cause mortality
(P=0.03).Thehazardratioformortalitywas4.7(2.6to8.5)
for absences with circulatory disease diagnoses, 2.2 (1.4
to 3.3) for surgical operations, and 1.9 (1.2 to 3.1) for
psychiatric diagnoses. Psychiatric absences were also
predictive of cancer mortality (2.5 (1.3 to 4.7)).
Associations of infectious, respiratory, and injury
absences withoverall mortalitywereless marked(hazard
ratios from 1.5 to 1.7), and there was no association
between musculoskeletal absences and mortality.
Conclusions Major diagnoses for medically certified
absences were associated with increased mortality, with
the exception of musculoskeletal disease. Data on
sickness absence diagnoses may provide useful
information to identify groups with increased health risk
and a need for targeted interventions.
INTRODUCTION
Theannualrateofmedicallycertifiedspellsofsickness
absenceseemstobeagoodglobalmeasureofhealth.
12
It reflects day to day functioning in occupational
settings and predicts mortality at least as well as more
established indicators of health such as poor self rated
health, minor psychiatric morbidity, and presence of
longstanding physical illness, disability, or infirmity.
3
The reasons for such good predictive power of the
overall rate of sickness absence are not well under-
stood. According to one hypothesis, sickness absence
spells may be a strong predictor of mortality because
they capture a wide range of illnesses that employees
experience.
3 An alternative view is that the increased
riskofearlymortalityisconfinedtospecificreasonsfor
absence such as cancer, heart disease, or surgery for
which increased mortality would be expected.
One way to clarify the reasons for the predictive
value of sickness absence in relation to mortality is to
include diagnoses for sickness absence in the analysis.
If sickness absence predicts mortality because it
captures the full range of illnesses which separately or
in combination increase death risk, then specific
diagnoses for absences would not improve prediction
of mortality compared with the overall sickness
absence rate. In contrast, sickness absence diagnoses
would contribute to predictive power if specific
diagnoses underlie the association between overall
sickness absence and mortality or if the strength of
association differs according to diagnosis.
In this study, we investigated whether diagnosis-
specificsicknessabsencepredictssubsequentmortality
from all causes and from specific causes in the
Whitehall II cohort of British civil servants. We also
determined whether including information on diag-
noses for sickness absence improved the prediction of
mortalitycomparedwithoverallsicknessabsencerates
irrespective of diagnoses.
METHODS
Participants
ThetargetpopulationfortheWhitehallIIstudywasall
Londonbasedofficestaffaged35-55workingin20civil
service departments. Baseline screening was carried
out between 1985 and 1988.
4 With a response rate of
73%, the final cohort consisted of 10308 (6895 men,
3413 women). The true response rate was higher,
however, because about 4% of those invited were not
eligible for inclusion. Ethical approval for the White-
hall IIstudywasobtainedfromthe UniversityCollege
London Medical School committee on the ethics of
human research.
Sickness absence
We obtained computerised sickness absence records
from 1 January 1985 onwards from civil service pay
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the start and end dates of all absences. For absences
longer than seven calendar days, a medical certificate
was required.
Diagnosis for absence was recorded in 12 of the 20
participating departments (61% of participants) from
1985onwardsandwasrecordedforall20departments
from 1991 onwards. The exposure in this study was
medically certified sickness absence during the first
three years for which diagnosis was recorded. For the
12 departments with full records of diagnosis for
absence, we used data on sickness absence during the
three years after the baseline screening date as the
exposure; for the other eight departments, where
recording of diagnosis was only available from 1991
onwards, we used data on sickness absence during the
three years from 1 January 1991 as the exposure time.
Sickness absence diagnoses were coded by the civil
service using a detailed coding system based on the
international classification of diseases (ICD-8). The
coding system was modified in 1990, with codes in the
oldsystem(942codes)mappedontoasmallernumber
ofcodes(586)inthenewsystem.Weconvertedthecivil
servicecodes to diseasecategoriesusingthe morbidity
coding system of the Royal College of General
Practitioners (RCGP). The RCGP disease categories
are similar to the ICD-8 chapter headings. We
modified the RCGP classification by adding four
extra disease categories (gastrointestinal, headache
and migraine, neurosis, neurosis ill-defined) that
accounted for a high proportion of sickness absence
spells. Further details on the coding of diagnoses into
the 25 disease categories (see box) have been reported
previously.
5
Weassessedthevalidityofthecivilservicediagnosis
codes by obtaining information from participants’
general practitioners for all absence spells lasting
>21 days in 1985-90: the civil service codes and
general practitioners showed agreement on disease
category for 64% of these absences.
6 We also checked
the sickness absence records for inconsistencies: we
mergedoverlapping,consecutive,orduplicatespellsof
sickness absence after taking account of weekends and
public holidays, and used the final diagnosis for
absence when we merged contiguous spells.
Mortality
We obtained mortality data for almost all the
participants (n=10297) up to 30 September 2004
from the National Health Service Central Register
mortalityregister.Inadditiontodeathsfromallcauses,
weanalyseddeathsfromcardiovasculardiseases(ICD-
9 codes 390-459, ICD-10 codes I00-I99) and cancer
(ICD-9 140-208, ICD-10 C00-C97). Smoking related
cancers were considered to be ICD-9 codes 140, 141,
143-150,157,160-163,188,and189andICD-10codes
C00-C06, C09-C15, C25, C30-C34, C38, and C64-
C68.
7
Other measures
Smoking, alcohol consumption (units consumed in
previous 7 days), presence of hypertension (use of anti-
hypertensivedrugsorbloodpressure>160/95mmHg),
body mass index (weight (kg)/(height (m)
2), self rated
health over the past 12 months, and presence of
longstanding illness, disability, or infirmity were
recorded at baseline. We created a composite physical
illness indicator (diabetes, diagnosed heart trouble,
electrocardiographic abnormalities, hypertension, and
respiratoryillness).Selfreporteddiagnosisofcancerwas
recorded at baseline and at phase 4 follow-up of the
WhitehallIIstudy(1995-6).Thereweremissingdatafor
the measure of longstanding illness as this was
introduced only after the start of the baseline survey:
where data were missing, we used reported long-
standing illness from the phase 2 follow-up survey
(1989-90).
Statistical analysis
For each employee, we computed the numbers of
medically certified spells(>7 days)of sicknessabsence
for each diagnostic category during the three year
exposure period. Diagnostic categories with small
numbers of participants were combined into an
“other” category. Follow-up for mortality was from
the first day after the three year exposure period until
30 September 2004. We used Cox’s proportional
ModifiedRCGPdiseasecategoriesusedinthisstudy
Code 1—Infectious and parasitic diseases
Code 2—Neoplasms
Code 3—Endocrine, nutritional, and metabolic diseases
Code 4—Diseases of blood and blood forming organs
Code 5—Psychoses
Code 6—Diseases of system
Code 7—Diseases of eye
Code 8—Diseases of ear
Code 9—Cardiovascular diseases
Code 10—Cerebrovascular diseases
Code 11—Peripheral vascular diseases
Code 12—Diseases of respiratory system
Code 13—Diseases of digestive system
Code 14—Diseases of genitourinary system
Code 15—Complications of pregnancy, childbirth, and puerperium
Code 16—Diseases of skin and subcutaneous tissue
Code 17—Diseases of musculoskeletal system and connective tissue
Code 20—Symptoms, signs, and ill-defined conditions
Code 23—Injury and poisoning
Code 35—General medical examinations and screening
Code 37—Surgical operations
Code 38—Gastrointestinal
Code 39—Headache and migraine
Code 40—Neurosis
Code 41—Neurosis ill-defined
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taken one or more spells of absence for each sickness
absence diagnostic category. The reference group was
participantswhohadnosicknessabsencespellslasting
>7 days duringthe exposureperiod. All analyseswere
adjusted for sex, age (in 5 year groups), and employ-
ment grade. If participants had two (or more) spells of
sicknessabsenceindifferentdiagnosticcategories,they
were included in both categories.
Using the likelihood ratio χ
2 test, we tested for an
improvement in predictive power for mortality by
taking account of absence diagnoses. We compared a
multivariate model including indicators for the main
diagnostic categories with the simpler model ignoring
diagnoses (any medically certified sickness absences
versus no such absences). We tested for the possibility
of differences in associations for women and men by
including an interaction term with sex. Further
analyses adjusted for other known predictors of
mortality (smoking, alcohol consumption, hyperten-
sion,andbodymassindex).Wetestedtheproportional
hazardsassumptionbyincludinganinteractionofeach
diagnosis-specific absence variable with the log of
follow-up time; in all cases, this interaction was not
statistically significant. We used the SAS 9.1 program
for all analyses.
RESULTS
Excluded participants
Of the 10308 participants in the Whitehall II study,
3830wereexcludedfromouranalysis(figure).Reasons
for exclusion were missing data on mortality (n=11) or
absencerecords(n=1124)andanincompletethreeyear
exposure period (n=2695; 120 died and 2575 left the
civil service during the exposure period). We
comparedmortalityafter1993intheremainingsample
of 6478 participants with the sample excluded from
analysis. After adjustment for age, sex, and employ-
mentgrade,mortalitywaslowerintheanalysedsample
than in the excluded sample (hazard ratio 0.81, 95%
confidence interval 0.67 to 0.98).
Overall sickness absence and mortality
Ofthe6478participants,288diedduringthefollow-up
period from the first day after the sickness absence
exposuretoSeptember2004.Meanfollow-upwas13.2
(SD 2.3, range 0.1-16.1) years. Mortality in the 12 civil
service departments where absence diagnoses were
recorded from baseline was similar to that in the other
eight departments where recording began in 1991
(hazard ratio 0.98, 0.74 to 1.31).
Table 1 shows the numbers of participants who had
one or more spells of medically certified sickness
absenceduringthe threeyearexposureperiod.Atotal
of 1906 employees (29%) had one or more such spells,
18% having one spell only and 11% having two or
more. Altogether, there were 3214 such spells of
absence, with a median length of 16 days.
Table 2 shows the associations of these spells of
absence with subsequent mortality, (adjusted for age,
Not linked to mortality data (n=11)
Civil service staff screened at baseline in 1985-8 (n=10 308)
Linked to mortality data (n=10 297)
Not linked to sickness absence records (n=1124)
Linked to sickness absence records (n=9173)
Staff with complete three year record of sickness
absences including diagnosis (n=6478)
Follow up for mortality  to 30 September 2004 (288 deaths)
In 12 out of 20 departments,
diagnoses for sickness
absences recorded from
baseline screening date
In 8 departments,
diagnoses for sickness
absences recorded from
1 January 1991 onwards
Staff with incomplete data for three
  year absence exposure period (n=2695):
    Died (n=120)
    Left civil service (n=2575)
Flow of participants through study
Table 1 |Distributionofspellsofmedicallycertifiedsickness
absenceduringthreeyearexposureperiodamongcivilservice
employees
No (%) of
participants
(n=6478)
No (%) of spells
of sickness
absence
Any medically certified spells of
sickness absence (lasting >7 days)
1906 (29.4) 3214 (100)
No of medically certified spells in
three years:
04 5 7 2 ( 7 0 . 6 ) —
11 1 7 0 ( 1 8 . 1 ) —
2 415 (6.4) —
3 183 (2.8) —
>3 138 (2.1) —
Diagnostic category for medically
certified spells (category code)*:
Infectious (1) 244 (3.8) 274 (8.5)
Respiratory (12) 685 (10.6) 850 (26.4)
Musculoskeletal (17) 257 (4.0) 305 (9.5)
Circulatory (9, 10, 11) 61 (0.9) 71 (2.2)
Injury (23) 230 (3.6) 255 (7.9)
Psychiatric (40, 41) 235 (3.6) 303 (9.4)
Surgery (37) 318 (4.9) 364 (11.3)
Other(2-8,13-16,20,35,38,39) 377 (5.8) 461 (14.3)
Not codeable or missing 289 (4.5) 331 (10.3)
Multiplemedicallycertifiedspells†:
2 spells same diagnosis 105 (1.7) —
2 spells different diagnoses 231 (3.7) —
>2 spells same diagnosis 27 (0.4) —
>2 spells different diagnoses 214 (3.5) —
*Modified RCGP morbidity coding system (see text for details).
†Among the 6189 participants with no missing or uncodeable
diagnoses.
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who had had one or more medically certified absence
in the three year exposure period mortality was 1.7
times higher than among those with no such absences,
and further adjustment for self rated health, long-
standing illness, and the composite physical illness
indicatorhadlittleeffectonthis(hazardratio1.59,1.16
to 2.17). We also found a dose-response association
between rates of medically certified absence with
subsequent mortality: compared with having no
medically certified absences, the hazard ratio for
having two or more medically certified absences was
1.97(1.43to2.71)andforhavingonesuchabsencewas
1.48 (1.11 to 1.98).
Diagnosis-specific sickness absence and mortality
The commonest diagnostic categories were respira-
tory, surgery, musculoskeletal, psychiatric, infectious
diseases, and injury—which together accounted for
73%ofallmedicallycertifiedabsencesinthethreeyear
exposure period. Among those participants who had
two or more absences, 77% had absences attributed to
two or more of the 25 different diagnostic categories.
As shown in table 2, medically certified absences
attributed to infectious diseases, respiratory diseases,
and injury had similar hazard ratios for mortality,
ranging from 1.5 to 1.7. The increased mortality risk
was greater, but not significantly so, for spells of
absence with a non-psychotic psychiatric diagnosis
(hazardratio1.9),andthisincreasedriskwasseenwith
both subcategories “neurosis” (1.9) and “neurosis ill-
defined” (2.0). Hazard ratios were higher for sickness
absences attributed to circulatory disease (4.7) and
surgical operations (2.2). Fewer than 10 people had
sickness absence attributed to cancer diagnoses; this
grouphadaparticularlyhighhazardratioof21.3(6.7to
67.4). Those having absence with a musculoskeletal
diagnosis did not have increased mortality compared
with participants who took no medically certified
absences (hazard ratio 1.0).
Comparisonofourmodelswithandwithoutsickness
absencediagnosesindicatedthatinclusionofdiagnoses
significantly improved the prediction of mortality (P
for improvement in χ
2=0.03). This statistical test of
improvement in model fit is equivalent to testing
whether hazard ratios for mortality vary by diagnosis.
Theonly diagnosiswhere the hazardratio for all cause
mortality significantly exceeded the hazard ratio of
1.66forallabsenceswascirculatorydisease(P<0.001).
None of the interactions between diagnostic cate-
goryandsexwassignificant.Havingmultipleabsences
with two or more different diagnoses during the three
year exposure period was associated with slightly
higher mortality, but this was not significant (hazard
ratio 1.34, 0.75 to 2.39, for ≥2 absences with different
diagnoses v ≥2 absences with same diagnosis).
Werepeatedanalysesafterexcludingthe31employ-
ees who died in the three years immediately after the
three year sickness absence exposure period, to
exclude the possibility that absence close to death
mightaccountforourfindings.Thehazardratioforany
medically certified absence compared with no such
absencewas1.59(1.23to2.07).Likewise,hazardratios
for diagnosis-specific absence were also hardly altered
(results not shown).
Sickness absence and cause-specific mortality
Table 3 presents associations between medically
certifiedspellsofabsenceandcause-specific mortality.
The two leading causes of death were cancer (144
deaths) and cardiovascular mortality (72 deaths),
accounting for 50% and 25% of all deaths. Other
causes (68 deaths) accounted for 24% of all deaths.
Causewasunknownforfourdeaths.Amongthecancer
deaths, 30% were assessed as smoking related.
Medically certified spells of sickness absence were
associated with both cardiovascular mortality (hazard
ratio 2.0) and cancer mortality (hazard ratio 1.7).
Absence attributable to psychiatric disorder showed a
strongerassociationwithcancermortality(hazardratio
2.5) than with cardiovascular mortality (hazard ratio
1.2), but the difference was not significant. The
association with cancer mortality was seen for both
psychiatric categories—“neurosis” (hazard ratio 2.2,
0.8 to 6.2) and “neurosis ill-defined” (3.0, 1.5 to 5.9)—
andwasalsoobservedinthesubgroupwhoseabsences
were all attributable to psychiatric disorder (hazard
ratio 2.4). To exclude the possibility that this associa-
tion might be explained by higher rates of sickness
absence for psychiatric causes among people with
cancer diagnosed, we repeated the analysis excluding
the 166 participants with a self reported diagnosis of
cancer either at baseline or follow-up in 1995-6. In the
subgroup without cancer, participants who had
absences with a psychiatric diagnosis had cancer
mortality 2.4 times higher (95% CI 1.2 to 4.6) than
did those with no absence.
Otherwise, rates of diagnosis-specific absence
tended to show stronger associations with
Table2 |Hazardratiosforallcausemortality(adjustedforage,sex,andemploymentgrade)among
6478civilserviceemployeesbyspecificdiagnosesformedicallycertifiedspellsofsickness
absence
Diagnostic category (category code)* No of participants (deaths) Hazard ratio (95% CI)
No medically certified sickness absence 4570 (161) 1.00
Any medically certified absence (all diagnoses): 1906 (127) 1.66 (1.30 to 2.13)
Infectious and parasitic diseases (1) 244 (15) 1.51 (0.88 to 2.59)
Circulatory (9-11) 61 (12) 4.68 (2.58 to 8.51)
Diseases of respiratory system (12) 685 (46) 1.63 (1.15 to 2.29)
Diseases of musculoskeletal system and
connective tissue (17)
257 (12) 1.04 (0.57 to 1.89)
Injury and poisoning (23) 230 (17) 1.66 (0.99 to 2.78)
Surgical operations (37) 318 (27) 2.16 (1.42 to 3.26)
Psychiatric (40, 41): 235 (19) 1.91 (1.17 to 3.11)
Neurosis (40) 87 (7) 1.91 (0.89 to 4.11)
Neurosis ill-defined (41) 164 (14) 2.03 (1.16 to 3.55)
Other (2-8, 13-16, 20, 35, 38, 39) 377 (27) 1.78 (1.17 to 2.70)
Diagnosis not codeable or missing 289 (22) 2.09 (1.33 to 3.30)
*Modified RCGP morbidity coding system (see text for details).
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although not significantly so. However, absences with
a musculoskeletal diagnosis were not associated with
either cardiovascular or cancer mortality. None of the
interactions between sex and diagnosis-specific
absence were significant either for cancer mortality or
cardiovascular mortality. Medically certified absences
were associated with mortality from suicide (ICD-9
codeE95,ICD-10codesX60-X84)orexternalcauseof
undetermined intent (ICD-9 E98, ICD-10 Y10-Y34)
(six deaths, hazard ratio 6.9, 1.2 to 39.1).
Adjustment for smoking, alcohol consumption,
body mass index, and hypertension did not remove
theassociationsofmedicallycertifiedsicknessabsence
with cause-specific mortality (table 4). As might be
expected, the association between absences with a
circulatorydiagnosisandcardiovascularmortalitywas
somewhat reduced after adjustment for these risk
factors, but it remained significant (hazard ratio 3.4).
However,adjustmentfortheseriskfactorsonlyslightly
attenuated the increased risk of cardiovascular mortal-
ity associated with absences for other diagnoses.
Absences for both psychiatric and non-psychiatric
causes maintained their associations with cancer
mortality after adjustment for risk factors.
Exclusion of participants who died in the first three
years after assessment of sickness absence had little
effect on hazard ratios for cause-specific mortality
(table 4). Similarly, when deaths in the first five years
were excluded, there was still a twofold increase in
cancer mortality among those having absences for
psychiatric reasons.
DISCUSSION
This study shows that knowing the diagnosis for
medically certified sickness absence from work sig-
nificantly improves the prediction of mortality.
Employees taking one or more medically certified
spells of absence (>7 days) for the common diagnostic
categories had increased mortality compared with
colleagues taking no medically certified absence. The
only exception was musculoskeletal absence, which
was not associated with increased mortality. Unex-
pectedly,employeeswhohadoneormoreabsencefor
psychiatricreasonshad a considerable 2.5-foldgreater
cancer mortality.
Comparison with other studies
Previous studies have shown that medically certified
absence rates predict all cause mortality,
38but to our
knowledge only one study, of very long term sickness
absence (>8 weeks),
9 has linked diagnosis-specific
sickness absence with mortality. While we found
associations with mortality for most diagnosis-specific
absences, this association was particularly strong for
absences with a cardiovascular diagnosis and for
absences with a psychiatric diagnosis, which is one of
themostcommondiagnoses.Wefoundnoassociation
between rates of absence for a musculoskeletal reason
and mortality—which is as expected as musculoskele-
tal disorders rarely cause death. The increased risk of
mortality among the few people who had absences
becauseofcancerisinlinewithfindingsfromtheabove
mentioned study of long term sickness absence in
Norway.
9
Few studies on sickness absence have examined
cause-specific mortality. We found that sickness
absence predicts both cardiovascular and cancer
mortality, the two leading causes of death in Western
societies, replicating findings for Finnish municipal
employees.
8 In that Finnish study the association
between sickness absence and cancer was stronger for
cancers not attributable to smoking. In our study most
of the cancer deaths (70%) were not considered to be
smokingrelated,
7andadjustmentforsmoking,alcohol
consumption, and body mass index made little
differencetoourresults,suggestingthattheassociation
between sickness absence and cancer mortality is not
due to these risk factors.
Table 3 |Hazardratiosforcause-specificmortality(adjustedforage,sex,andemploymentgrade)among6478civilserviceemployeesbyspecificdiagnosesfor
medicallycertifiedspellsofsicknessabsence
Diagnostic category (category code)*
Mortality
Cardiovascular (72 deaths) Neoplasms (144 deaths) Other (68 deaths)
No of deaths Hazard ratio (95% CI) No of deaths Hazard ratio (95% CI) No of deaths Hazard ratio (95% CI)
No medically certified sickness absence 36 1.00 80 1.00 41 1.00
Any medically certified absence (all
diagnoses):
36 1.96 (1.20 to 3.21) 64 1.73 (1.22 to 2.45) 27 1.39 (0.83 to 2.33)
Infectious and parasitic diseases (1) 5 2.14 (0.82 to 5.60) 6 1.24 (0.53 to 2.88) 4 1.56 (0.55 to 4.46)
Circulatory (9-11) 5 6.20 (2.35 to 16.3) 3 2.59 (0.81 to 8.29) 4 6.51 (2.27 to 18.7)
Diseases of respiratory system (12) 15 2.23 (1.18 to 4.21) 21 1.52 (0.92 to 2.51) 10 1.40 (0.68 to 2.88)
Diseases of musculoskeletal system and
connective tissue (17)
3 0.98 (0.30 to 3.25) 5 0.93 (0.37 to 2.33) 4 1.40 (0.49 to 4.00)
Injury and poisoning (23) 4 1.62 (0.50 to 4.67) 4 0.82 (0.30 to 2.28) 9 3.58 (1.68 to 7.66)
Surgical operations (37) 8 2.85 (1.31 to 6.22) 12 1.94 (1.05 to 3.59) 7 2.19 (0.97 to 4.95)
Psychiatric (40, 41) 3 1.24 (0.37 to 4.09) 12 2.49 (1.33 to 4.68) 4 1.61 (0.56 to 4.62)
Other (2-8, 13-16, 20, 35, 38, 39) 8 2.16 (0.98 to 4.75) 12 1.63 (0.87 to 3.02) 7 1.83 (0.80 to 4.17)
Diagnosis not codeable or missing 4 1.64 (0.57 to 4.69) 14 2.77 (1.54 to 4.97) 4 1.46 (0.51 to 4.16)
*Modified RCGP morbidity coding system (see text for details).
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related to all cause and cancer mortality? This was not
due to confounding by health behaviours because
adjustment for smoking and alcohol consumption
hardly altered our results. Several studies have found
that depression and negative affective dispositions,
such as neuroticism and dispositional anxiety, are risk
factors for all cause mortality and cardiovascular
mortality.
10-13 The large population based Norwegian
HUNT study showed that depression predicted sub-
sequent cancer mortality as well as cardiovascular
mortality.
14 One possible explanation for the associa-
tion is that depression may interfere with help seeking
behaviour,
14 as survival is often related to early
detection of cancer. A further possible explanation is
thatpsychiatricdisordersaffectcancerprognosisrather
than aetiology.
15 Depression may also impair adher-
ence to cancer treatment, although recent reviews on
breast cancer found no conclusive evidence that
psychological factors influence survival or
relapses.
1617 It is also possible that these psychiatric
diagnoses are early symptoms of undiagnosed cancer.
For example, the subcategory “neurosis ill-defined”
included tiredness and stress, which could be early
symptoms of undiagnosed cancer or other physical
illness. However, excluding deaths in the first three
years did not alter our results, and we still found a
twofold increase in cancer mortality after we excluded
deaths in the first five years.
Strengths and limitations
The strengths of our study were the large sample
coveringawiderangeofemploymentgradesfromlow
to high incomes, the long follow-up for mortality, the
use ofreliablemortalityregisters,and the highvalidity
of sickness absence data that included information on
diagnosis.
Some limitations are noteworthy. Firstly, some data
onsicknessabsencediagnosisweremissingintheearly
yearsoftheWhitehallIIstudy.Thisisunlikelytohave
led to biased results, as associations of overall sickness
absence with mortality from all causes, cancer, and
cardiovascular disorders were similar in the total
sample and in the sample analysed in this study.
Secondly, numbers of deaths were small in some of
the diagnostic categories for sickness absence, and our
results therefore need replication. There was insuffi-
cient power for detailed analyses of, for example,
duration of sickness absence spells or less common
diagnosesforabsence.Ourstudyalsohadlowpowerto
detect sex differences or to examine whether the
association of sickness absence with mortality differed
according to employment grade. Previous findings
from this cohort showed that there are sex differences
in rates of medically certified absences after taking
account of age and employment grade: women had
higher rates for absences with respiratory, psychiatric,
or surgery diagnoses; similar rates for musculoskeletal
and injury; and a non-significantly lower rate for
cardiovascular diagnoses.
6
Thirdly, the recorded diagnosis for a sickness
absence may not cover all of the actual causes as
sicknessabsenceisacomplexmultifactorialbehaviour
and there may not be a simple relation between illness
and taking of sick leave.
18 Only one diagnosis is
recorded for each sick leave, and thus coexisting
diseases are not covered. Moreover, the stage and
severity of disease when affected individuals decide to
take sick leave may vary between diagnoses, and this
might account for some of the differences in excess
mortality between sickness absence diagnoses.
Conclusions and policy implications
Sickness absence is a serious economic problem with
largecostsforhealthcareandmanylostworkinghours
for businesses.
218 We found that the almost 30% of
participants who had a sickness absence spell of more
than seven days over a three year period had a 66%
increased risk of premature death. We do not consider
Table 4 |Hazardratiosforcause-specificmortalityamongcivilserviceemployeesbyspecificdiagnosesformedicallycertifiedspells
ofsicknessabsence
Diagnostic category*
Hazard ratio (95% CI)
Adjusted for age, sex,
and grade (model A)
Model A+ adjusted forsmoking,alcohol,
body mass index, and hypertension
Model A with three year
washout period†
Cardiovascular mortality (68 deaths/6255 participants) (59 deaths/
6218 participants)
No medically certified sickness absence 1.00 1.00 1.00
Anymedicallycertifiedabsence(alldiagnoses): 2.24 (1.35 to 3.71) 1.97 (1.18 to 3.30) 2.18 (1.28 to 3.36)
Circulatory 5.93 (2.04 to 17.3) 3.42 (1.13 to 10.4) 7.71 (2.62 to 22.7)
Other diagnoses 2.08 (1.24 to 3.49) 1.88 (1.11 to 3.19) 1.97 (1.12 to 3.46)
Cancer mortality (134 deaths/6255 participants) (118 deaths/
6218 participants)
No medically certified sickness absence 1.00 1.00 1.00
Anymedicallycertifiedabsence(alldiagnoses): 1.84 (1.28 to 2.65) 1.75 (1.21 to 2.52) 1.83 (1.24 to 2.70)
Psychiatric 2.64 (1.37 to 5.08) 2.44 (1.26 to 4.70) 2.27 (1.07 to 4.82)
Other diagnoses 1.74 (1.19 to 2.54) 1.65 (1.13 to 2.43) 1.77 (1.18 to 2.65)
*Modified RCGP morbidity coding system (see text for details).
†Washout period=exclusion of participants who died in the first three years after assessment of sickness absence.
RESEARCH
page 6 of 7 BMJ | ONLINE FIRST | bmj.comthat the taking of sick leave itself is a risk behaviour.
Instead,itmaybeamarkerofcircumstancesandhealth
problems that increase mortality. We believe that
better monitoring of diagnosis-specific absences at
population levels may be useful and contribute to
policymaking—notonly asa measure ofcosts butalso
asdatatoidentifygroupsatincreasedhealthriskandin
need of targeted intervention.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Rates of medically certified sickness absence from work are associated with increased all
cause mortality
Itisnotknownwhetherthisassociationisrestrictedtospecificdiagnosesforsicknessabsence
WHAT THIS STUDY ADDS
All the common diagnostic categories for sickness absence predicted overall mortality, with
the exception of musculoskeletal diagnoses
Sicknessabsencewithapsychiatricdiagnosis,oneofthecommonestdiagnosesformedically
certified absence, was a strong predictor of cancer related mortality
Routinelycollecteddataonsicknessabsencesthatincludethediagnosismayhelptoidentify
groups at increased risk of fatal disease and allow targeted early interventions
RESEARCH
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